Eli Lilly & Co. (NYSE: LLY) – Q1 2025 Earnings Analysis● Analysis BackgroundOn May 1, 2025, Eli Lilly & Co. reported its financial results for the first quarter of 2025. The company showcased significant revenue growth driven by its key products, Mounjaro and Zepbound. This report provides a detailed analysis of the company's performance, strategic initiatives, and investment considerations base..